Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-05-28Clinical Trial Update: Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder [NA]
This clinical trial update discusses investigating breathing meditation in combination with methylphenidate for treating attention-deficit/h…
-
FDA approval · 2010-05-27FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for clonidine hydrochloride from Solco Healthcare LLC, approving the generic product's submission.
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Salivary Bacteria and Oral Health Status in Children With ADHD
A completed clinical trial from Hadassah Medical Organization evaluating salivary bacteria and oral health status in children with ADHD, foc…
-
CLINICAL_TRIALS research · 2010-05-14Clinical Trial Update: A Double Blind Crossover Study on the Effect of Methylphenidate on Decision-making Ability of Adults With ADHD Compared to Healthy Adults [NA]
A clinical trial update describing a double-blind crossover study assessing how methylphenidate affects decision-making in adults with ADHD …
-
FDA approval · 2010-05-10FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (TruPharma, LLC)
The FDA approved a supplemental application for clonidine hydrochloride from TruPharma, LLC, as part of an existing ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD) [Phase 3]
A Phase 3 clinical trial evaluated the efficacy and effectiveness of methylphenidate in Swedish male prison inmates with ADHD. The study has…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD [Phase 4]
Phase 4 clinical trial evaluating the combination of atomoxetine and OROS methylphenidate for treating ADHD in children and adolescents aged…
-
FDA approval · 2010-05-04FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder [Phase 3]
This is a Phase 3 effectiveness and safety study of CONCERTA (methylphenidate hydrochloride) in adolescents with attention-deficit/hyperacti…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating atomoxetine in adolescents with coexisting ADHD and alcohol/subst…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder [Phase 4]
A Phase 4 clinical trial evaluated effective and tolerable titration schemes for OROS-Methylphenidate in children with Attention-Deficit/Hyp…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)
The COSMOS study, a completed clinical trial sponsored by Johnson & Johnson Taiwan, investigates compliance with ADHD medications to improve…
-
FDA approval · 2010-04-27FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for methylphenidate submitted by Sandoz Inc.
-
FDA approval · 2010-04-21FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Original Application (Mayne Pharma Commercial LLC)
FDA approved a generic methamphetamine hydrochloride product under an original ANDA from Mayne Pharma Commercial LLC, applicable to ADHD and…
-
CLINICAL_TRIALS trial_result · 2010-04-21Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]
Phase 3 study evaluating the effectiveness and safety of prolonged-release OROS methylphenidate in adults with ADHD has completed and result…
-
CLINICAL_TRIALS trial_result · 2010-04-20Clinical Trial Update: A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents [Phase 3]
Phase 3 clinical trial comparing atomoxetine with standard care in children and adolescents with ADHD to assess long-term functioning; trial…
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 1]
Phase 1 study assessing pharmacokinetics, safety and tolerability after a single dose of JNJ-31001074 in children aged 6-11 with attention-d…
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 1]
A Phase 1 trial evaluating pharmacokinetics, safety and tolerability of a single dose of JNJ-31001074 in pediatric patients aged 12-17 with …
-
CLINICAL_TRIALS research · 2010-04-13Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children [Phase 4]
This entry notes a Phase 4 clinical trial evaluating the efficacy and tolerability of omega-3 fatty acid supplementation in children with At…
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD [Phase 3]
This clinical trial update reports completion of a Phase 3 study evaluating CLONICEL (clonidine sustained-release) as an add-on to stimulant…
-
CLINICAL_TRIALS trial_result · 2010-04-06Clinical Trial Update: Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) [Phase 4]
A Phase 4 trial compared atomoxetine to placebo in children with ADHD and/or reading disorder; results were posted in 2010.
-
FDA approval · 2010-04-05FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental NDA for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, detailing a label/indication …
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 study evaluating the safety and efficacy of CLONICEL for children and adolescents with Attention-Deficit/Hyperactivity Disorder has …
-
FDA approval · 2010-03-11FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (TruPharma, LLC)
The FDA approved a supplemental application for clonidine hydrochloride (generic) from TruPharma, LLC.
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes [Phase 4]
Phase 4 clinical trial evaluating atomoxetine in young adults with ADHD and its effects on functional outcomes; results were posted in 2010.